Author： Burton A.
Publisher： Elsevier
ISSN： 1473-3099
Source： The Lancet Infectious Diseases, Vol.2, Iss.12, 2002-12, pp. : 713-713
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The African Green Monkey model for cutaneous and visceral leishmaniasis
By Olobo J.O. Gicheru M.M. Anjili C.O.
Trends in Parasitology, Vol. 17, Iss. 12, 2001-12 ,pp. :
Access to resources
Recommend
Heated amphotericin to treat leishmaniasis
By Bau P. Bolard J. Dupouy-Camet J.
The Lancet Infectious Diseases, Vol. 3, Iss. 4, 2003-04 ,pp. :
Miltefosine in visceral leishmaniasis
By Olliaro P.L. Ridley R.G. Engel J. Sindermann H. Bryceson A.D.M.
The Lancet Infectious Diseases, Vol. 3, Iss. 2, 2003-02 ,pp. :
Visceral Leishmaniasis: Advances in Treatment
Recent Patents on Anti-Infective Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. :
Post-kala-azar dermal leishmaniasis
By E Zijlstra E. M Musa A. A G Khalil E. M El Hassan I. M El-Hassan A.
The Lancet Infectious Diseases, Vol. 3, Iss. 2, 2003-02 ,pp. :